Bowel management program in patients with spina bifida.
Bowel management
Constipation
Enema
Fecal incontinence
Myelomeningocele
Neurogenic bowel
Spina bifida
Journal
Pediatric surgery international
ISSN: 1437-9813
Titre abrégé: Pediatr Surg Int
Pays: Germany
ID NLM: 8609169
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
accepted:
18
10
2018
pubmed:
8
11
2018
medline:
15
3
2019
entrez:
8
11
2018
Statut:
ppublish
Résumé
Our center has been successfully implementing a bowel management program (BMP) for fecal incontinence consecutive to anorectal malformation and Hirschsprung disease. Recently, the number of patients with spina bifida requiring management for fecal incontinence has increased. The purpose of this study was to review the results of bowel management in patients with spina bifida and the challenges unique to this population. A retrospective chart review was performed including all patients with spina bifida who attended our BMP from February 2016 until April 2018. Data collection included: prenatal intervention, gender, age, characteristics of contrast enema, success rateand challenges faced. Twenty-two patients met inclusion criteria 13 of which were females. Three patients had their myelomeningocele repaired prenatally, the remaining were repaired postnatally. Patient ages ranged from 2 to 24 years. Only nine patients were referred to BMP at proper toilet training age. Three patients came to BMP status post an antegrade enema procedure with reported "accidents" on their current regimen. The colon in the contrast enema was non-dilated in all patients and two behaved as hypermotile requiring loperamide. Seventeen patients (77%) were clean of stool and considered successful. Solution leakage during enema administration was the most common challenge and was corrected by increasing the Foley balloon fill volume. Our bowel management program with enemas is effective for patients with a history of spina bifida. The data support specific considerations for this population including frequent adjustments, close follow-up and specific administration techniques.
Identifiants
pubmed: 30402681
doi: 10.1007/s00383-018-4403-5
pii: 10.1007/s00383-018-4403-5
doi:
Substances chimiques
Antidiarrheals
0
Loperamide
6X9OC3H4II
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
243-245Références
J Pediatr Urol. 2013 Jun;9(3):267-71
pubmed: 22521622
Spinal Cord. 2013 May;51(5):384-8
pubmed: 23439065
J Pediatr Urol. 2014 Apr;10(2):219-22
pubmed: 24439630
Pediatr Surg Int. 2016 May;32(5):471-6
pubmed: 26875175
J Pediatr Surg. 2017 Apr;52(4):554-557
pubmed: 27634558